Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.

Autor: Thompson MC; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Harrup RA; Royal Hobart Hospital, Tasmania, Australia., Coombs CC; University of North Carolina, Chapel Hill, NC., Roeker LE; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Pu JJ; University of Arizona Cancer Center, Tuscon, AZ., Choi MY; University of California, San Diego, San Diego, CA., Barr PM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Allan JN; Weill Cornell Medicine, New York, NY., Šimkovič M; University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic., Leslie L; Hackensack University Medical Center, Hackensack, NJ., Rhodes J; Northwell Health Cancer Institute, Lake Success, NY., Chong EA; University of Pennsylvania, Philadelphia, PA., Kamdar M; University of Colorado Cancer Center, Denver, CO., Skarbnik A; Novant Health, Charlotte, NC., Lansigan F; Dartmouth-Hitchcock Medical Center, Lebanon, NH., McCall B; Dartmouth-Hitchcock Medical Center, Lebanon, NH., Saja K; Colchester General Hospital, East Suffolk, and North Essex NHS Foundation Trust, Essex, United Kingdom., Dyer MJS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Walter HS; The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom., Lefebure M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Thadani-Mulero M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Boyer M; Roche Products Ltd, Welwyn Garden City, United Kingdom., Biondo J; Genentech, Inc., South San Francisco, CA., Sail K; AbbVie, Inc., North Chicago, IL., Manzoor BS; AbbVie, Inc., North Chicago, IL., Furman R; Weill Cornell Medicine, New York, NY., Bantilan KS; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Goy A; Hackensack University Medical Center, Hackensack, NJ., Feldman T; Hackensack University Medical Center, Hackensack, NJ., Labella D; Riverside Regional Medical Center, Newport News, VA., Schuster SJ; University of Pennsylvania, Philadelphia, PA., Park J; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Palomba L; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Zelenetz A; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Kater AP; Amsterdam University Medical Centers, Amsterdam, The Netherlands; and., Seymour JF; Royal Melbourne Hospital, Peter McCallum Cancer Centre, and University of Melbourne, Melbourne, Australia., Mato AR; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2022 Aug 09; Vol. 6 (15), pp. 4553-4557.
DOI: 10.1182/bloodadvances.2022007812
Databáze: MEDLINE